During an inspection in Beijing, Xi required accelerating the selection, research and development of drugs with good clinical effects.
He also called on universities, research institutes and enterprises to redouble efforts in the research and development of reagents, vaccines and drugs for early breakthroughs.
FEBRUARY 12
Xi chaired a meeting of the Standing Committee of the Political Bureau of the CPC Central Committee which urged greater efforts in the research and development of drugs and vaccines.
FEBRUARY 14
Addressing a meeting of the central committee for deepening overall reform, Xi encouraged the use of digital technologies such as big data, artificial intelligence, cloud computing to support the epidemic surveillance and analysis, virus source tracing, epidemic prevention and control, disease treatment, and allocation of resources.
FEBRUARY 21
Xi chaired a meeting of the Political Bureau of the CPC Central Committee, which called for more support for the research and development of reagents, drugs and vaccines.
FEBRUARY 23
At a meeting on coordinating the COVID-19 prevention and control and economic and social development, Xi said "because COVID-19 is a new infectious disease, our understanding of it remains relatively preliminary."
He called for multidisciplinary scientific research, highlighting the theoretical research on source of infection, transmission and pathogenesis to help produce more targeted and practical guidelines for COVID-19 prevention and control after work and production resume.
【国内英语资讯:Xi Focus-Timeline: Xi leads China to fight COVID-19 with sci-tech】相关文章:
★ 卡尼面临的挑战
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15